James L Rubenstein

6PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 13, 2024
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.

Huimin Geng, Shirley Mo, Lingjing Chen

|Sep 30, 2022
Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation.

James L Rubenstein

|Jul 31, 2021
A functional mammalian display screen identifies rare antibodies that stimulate NK cell-mediated cytotoxicity.

Emily Kang, Cigall Kadoch, James L Rubenstein

|Jun 09, 2020
On point in primary CNS lymphoma.

Mazie Tsang, Joseph Cleveland, James L Rubenstein

Pageof 1